Platypus Technologies, LLC: Receives $1.65 Million Phase II Small Business Innovation Research (SBIR) Grant

Platypus Technologies, LLC
5520 Nobel Drive, Suite 100
Madison, WI 53711

Platypus Technologies, LLC has received a Phase II Small Business Innovation Research (SBIR) grant for $1.65 million from the National Institute for Allergy & Infectious Diseases. The grant is to continue development of the company’s proprietary liquid crystal based technology to enable rapid detection of antibodies to infectious agents. This technology will advance the ability to monitor the spread of diseases such as avian influenza and will also be useful in vaccine development. Platypus Technologies has received over $11.5 million in SBIR funding to develop products for the physical and life sciences. The Company has 19 employees and is located in the Fitchburg Technology Campus.

For more information contact: Barbara Israel, CEO
237-1274
bisrael@platypustech.com